Inspire Medical Systems(INSP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INSP Inspire Medical Systems

Pre-Market Trading 03-27 08:54:19 EDT

163.19

-1.76

-1.07%

盘前162.24

-0.95-0.58%

08:02 EDT

High167.92	Low162.55	Vol293.22K
Open164.17	D1 Closing164.95	Amplitude3.26%
Mkt Cap4.84B	Tradable Cap4.77B	Total Shares29.67M
T/O48.16M	T/O Rate1.00%	Tradable Shares29.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"INSP","market":"US","secType":"STK","nameCN":"Inspire Medical Systems","latestPrice":163.19,"timestamp":1743019200000,"preClose":164.95,"halted":0,"volume":293224,"hourTrading":{"tag":"盘前","latestPrice":162.24,"preClose":163.19,"latestTime":"08:02 EDT","volume":13,"amount":2119.50999,"timestamp":1743076977236},"delay":0,"floatShares":29199556,"shares":29669407,"eps":1.75,"marketStatus":"Pre-Market Trading","change":-1.76,"latestTime":"03-27 08:54:19 EDT","open":164.17,"high":167.92,"low":162.55,"amount":48155072.06552,"amplitude":0.032555,"askPrice":179,"askSize":8,"bidPrice":148.38,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.75,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743082200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1525320000000,"exchange":"NYSE","adjPreClose":163.19,"preHourTrading":{"tag":"盘前","latestPrice":162.24,"preClose":163.19,"latestTime":"08:02 EDT","volume":13,"amount":2119.50999,"timestamp":1743076977236},"postHourTrading":{"tag":"盘后","latestPrice":163.19,"preClose":163.19,"latestTime":"19:48 EDT","volume":26706,"amount":4358157.99,"timestamp":1743032887942},"volumeRatio":0.7205356493077066,"impliedVol":0.6256,"impliedVolPercentile":0.5422},"requestUrl":"/m/hq/s/INSP/tweets","defaultTab":"tweets","newsList":[{"id":"2519865959","title":"BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail","url":"https://stock-news.laohu8.com/highlight/detail?id=2519865959","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519865959?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 00:59","pubTimestamp":1741885140,"startTime":"0","endTime":"0","summary":"Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive currency exposure and general macroeconomic headwinds. The stock carries a Zacks Rank #3  currently.On the flip side, present global economic challenges and uncertainties have made it harder for Bruker to manage operations and predict financial outcomes. Geopolitical conditions, including conflicts in Russia and Ukraine, Israel, Palestine and surrounding areas, tensions between the United States and China, along with potential energy shortages in Europe increased energy and transportation costs, are impacting the company’s operational results. In addition, supply-chain risks associated with inflation, the threat of recession, currency volatility, and the worldwide shortage of semiconductor chips, components and raw materials such as copper also persist. All these issues are leading to higher cost","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biospins-innovations-support-bruker-shares-165900758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211328371.USD","LU0792757196.USD","LU1815336091.USD","LU1571399168.USD","BK4167","LU0162691827.USD","LU0072461881.USD","LU0310799852.SGD","LU0211327993.USD","LU1267930490.SGD","BK4121","BK4585","LU0757428866.USD","LU0052756011.USD","BK4175","LU0310800965.SGD","LU0128525689.USD","LU1880398471.USD","BRKR","BK4588","LU0154236417.USD","BK4082","LU0889566641.SGD","LU1267930227.SGD","BK4196","CAH","LU0006061336.USD","SG9999001440.SGD","LU2065731478.USD","LU1880398554.USD","LU1267930813.SGD","INSP"],"gpt_icon":1},{"id":"2518672833","title":"Investors in Inspire Medical Systems (NYSE:INSP) have seen splendid returns of 248% over the past five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2518672833","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518672833?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 22:22","pubTimestamp":1741702972,"startTime":"0","endTime":"0","summary":"The worst result, after buying shares in a company , would be if you lose all the money you put in. But on a lighter note, a good company can see its share price rise well over 100%. For instance, the price of Inspire Medical Systems, Inc.  stock is up an impressive 248% over the last five years. It's down 1.7% in the last seven days.So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.Check out our latest analysis for Inspire Medical Systems. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share  and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.During the last half decade, Inspire Medical Systems became profitable. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-inspire-medical-systems-nyse-142252388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INSP","LU2065731478.USD","BK4211","BK4082","BK4167","ISBC","NYSE"],"gpt_icon":0},{"id":"2518216127","title":"ALGN Stock to Benefit From the Launch of Align X-ray Insights Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2518216127","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518216127?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 22:11","pubTimestamp":1741702260,"startTime":"0","endTime":"0","summary":"Align Technologies ALGN has launched Align X-ray Insights, an AI-powered software-based  computer-aided detection solution to automatically analyze 2D radiographs across the European Unioncountries and theUnited Kingdom. Part of the Align Digital Platform, the software is designed to support doctors in diagnosing dental and oral health conditions, standardizing analysis, streamlining workflows and improving patient engagement.The company will showcase the solution at the IDS tradeshow inCologne, Germany, fromMarch 25 to 29, 2025.After the announcement yesterday, shares of ALGN decreased 5.9%, finishing the session at $163.39. On a promising note, the latest development represents a significant advancement in the company’s digital restorative dentistry solutions with wider patient applicability. With the integration of AI into radiographic analysis, the launch underscores its commitment to innovation and ongoing efforts to expand the digital platform. Accordingly, we expect the news to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/algn-stock-benefit-launch-align-141100140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4175","LU0006061336.USD","LU2023250504.SGD","LU2106854487.HKD","LU1571399168.USD","LU0162691827.USD","BK4588","SG9999001440.SGD","BK4534","LU0310799852.SGD","BK4504","LU1267930813.SGD","LU1880398471.USD","LU1974910355.USD","LU0072461881.USD","CAH","LU1880398554.USD","LU0792757196.USD","LU0052756011.USD","LU0154236417.USD","ALGN","LU0211327993.USD","BK4585","LU0211328371.USD","LU2065731478.USD","LU1267930227.SGD","LU2023250843.SGD","LU0310800965.SGD","BK4167","LU0889566641.SGD","BK4196","INSP","LU1917777945.USD","LU0128525689.USD","BK4198","LU1267930490.SGD"],"gpt_icon":1},{"id":"2517433656","title":"QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433656","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517433656?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 19:35","pubTimestamp":1741347300,"startTime":"0","endTime":"0","summary":"QIAGEN N.V.QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, bolstering its syndromic testing portfolio in the United States. This marks the company’s second FDA clearance of a QIAstat-Dx panel in 2025, building on the authorization of five panels for use on the QIAstat-Dx system in the last 10 months.With the latest development, QIAGEN now has regulatory clearances for three mini panels for the detection of respiratory and gastrointestinal conditions. These panels are designed for fast and informed treatment decisions in outpatient settings.QIAGEN has a market capitalization of $8.55 billion. The company’s earnings yield of 5.8% compares favorably to the industry average of -32.8% yield. In the trailing four quarters, it delivered an average earnings surprise of 3.6%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qgen-stock-fda-nod-second-113500024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999001440.SGD","LU0072461881.USD","LU1923622614.USD","STEC","LU2065731478.USD","BK4167","LU1880398471.USD","LU1880398554.USD","LU0310800965.SGD","CAH","BK4082","LU0211328371.USD","LU0052756011.USD","LU2125909593.SGD","BK4175","LU0310799852.SGD","LU0792757196.USD","BK4196","INSP","BK4135","LU0162691827.USD","LU2125909247.SGD","LU0128525689.USD","LU0006061336.USD","QGEN","LU1267930227.SGD","LU2433249047.HKD","LU0211327993.USD","BK4121","LU1571399168.USD","LU0889566641.SGD","BK4588","LU1267930813.SGD","BK4585","LU0154236417.USD","LU1267930490.SGD"],"gpt_icon":1},{"id":"2517915472","title":"Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2517915472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517915472?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, March  06, 2025  (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, min","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038122/0/en/Inspire-Medical-Systems-Inc-to-Present-at-the-KeyBanc-Capital-Markets-Healthcare-Forum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FET","BK4137","BK4179","BK4082","BK4167","LU2065731478.USD","INSP","HCSG"],"gpt_icon":0},{"id":"2517165627","title":"Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165627","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517165627?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"Bruker CorporationBRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope  using micro-Computed Tomography . Representing a significant leap in benchtop XRM design and performance, it offers advanced capabilities similar to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demanding XRM applications.The X4 POSEIDON is designed for use in industrial applications and scientific research.Since the announcement on Feb. 27, shares of Bruker have lost 7.2%, finishing at $46.87 yesterday. On a promising note, the company fosters innovation, improved productivity and customer success in post-genomic life science molecular and cell biology research. Bruker’s differentiated systems and solutions support research in the fields of preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as clinical microbiology and molecular d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bruker-stock-benefit-launch-x4-130000142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BRKR","LU0211328371.USD","LU1267930490.SGD","BK4588","BK4175","LU0757428866.USD","LU0154236417.USD","LU0072461881.USD","LU1267930227.SGD","LU1880398554.USD","BK4097","LU1815336091.USD","BK4167","LU0128525689.USD","CAH","SG9999001440.SGD","LU0162691827.USD","LU2065731478.USD","LU0310799852.SGD","AIP","LU0006061336.USD","BK4082","LU1571399168.USD","LU0211327993.USD","LU0792757196.USD","BK4196","LU1267930813.SGD","INSP","LU0889566641.SGD","LU1880398471.USD","LU0310800965.SGD","BK4585","LU0052756011.USD","BK4121"],"gpt_icon":1},{"id":"2517967156","title":"Inspire Medical Systems (INSP) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517967156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517967156?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 19:54","pubTimestamp":1741262049,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Adam Maeder reiterated a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of $233....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inspire-medical-systems-insp-receives-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inspire-medical-systems-insp-receives-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","BK4082","BK4167","INSP"],"gpt_icon":0},{"id":"2517954278","title":"Is Inspire Medical Systems, Inc. (INSP) the Best Medical Technology Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517954278","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517954278?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 12:53","pubTimestamp":1741150435,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts.In this article, we are going to take a look at where Inspire Medical Systems, Inc.  stands against the other medical technology stocks.The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment. Prominent products in this field include well-known devices like pacemakers, imaging equipment, dialysis machines, and a range of implants.A study by Mordor Intelligence estimates that the medical equipment market will be worth $681.57 billion by 2025. The enormous industry is anticipated to reach a market value of $955.49 billion by the end of the forecast period, growing at a compound yearly growth rate of 6.99% between 2025 and 2030.McKinsey predicts that the growth dynamics of the healthcare sector will continue to change. Between 2023 and 2028, it is projected that revenue pools related to h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspire-medical-systems-inc-insp-045355048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HST","BK4167","BK4588","LU2065731478.USD","BK4082","INSP","BK4585","BK4218","BK4181"],"gpt_icon":0},{"id":"2516731674","title":"1 Small-Cap Stock to Own for Decades and 2 to Ignore","url":"https://stock-news.laohu8.com/highlight/detail?id=2516731674","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516731674?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 21:06","pubTimestamp":1741093560,"startTime":"0","endTime":"0","summary":"Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here is one small-cap stock that could amplify your portfolio’s returns and two that may have trouble.Founded by the former Mirage Resorts CEO, Wynn Resorts  is a global developer and operator of high-end hotels and casinos, known for its luxurious properties and premium guest services.Demand will likely fall over the next 12 months as Wall Street expects flat revenue. Below-average returns on capital indicate management struggled to find compelling investment opportunities. Inspire Medical Systems’s stock price of $182 implies a valuation ratio of 93.3x forward price-to-earnings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-small-cap-stock-own-130600504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2362541273.HKD","BK4167","BK4503","SGXZ23171101.USD","SG9999004303.SGD","BK4123","LU2362540622.SGD","BK4588","BK4585","INSP","KBR","BK4150","LU0053671581.USD","LU2065731478.USD","WYNN","BK4082","LU2362541513.USD"],"gpt_icon":0},{"id":"2516967099","title":"BSX Stock Set to Gain From the New Agreement to Acquire SoniVie Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967099","media":"Zacks","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516967099?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 20:55","pubTimestamp":1741092900,"startTime":"0","endTime":"0","summary":"Boston Scientific, Inc.BSX has signed a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that developed the TIVUS Intravascular Ultrasound System.The company already holds an approximately 10% stake in SoniVie. Hence, it will pay nearly $360 million upfront to acquire the remaining 90%, with up to $180 million contingent on regulatory milestones.The transaction is expected to close in the first half of 2025, subject to customary closing conditions.After yesterday’s announcement, BSX shares rose 1% to finish the session at $104.87. Renal denervation has emerged as a promising medical advancement in the hypertension space, supported by strong clinical evidence and ongoing research. The latest development enhances Boston Scientific’s interventional cardiology therapy offerings with a minimally invasive therapy for patients with hypertension and also provides the opportunity for future innovation in this field. We expect the market sentiment surrounding","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bsx-stock-set-gain-agreement-125500450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAH","INSP","LU0187121727.USD","LU0072461881.USD","LU1989764748.USD","LU1023059063.AUD","BK4196","LU0353189680.USD","IE00BJJMRZ35.SGD","LU1829250122.USD","LU0128525689.USD","LU0114720955.EUR","LU2362541513.USD","LU2491050071.SGD","BP","LU1162221912.USD","LU1880398471.USD","LU2506951875.HKD","LU0345769128.USD","LU0528227936.USD","LU0211327993.USD","IE0002141913.USD","LU1989764664.SGD","LU0251132253.USD","LU2242649171.HKD","LU1791710582.SGD","BK4175","BK4581","LU0077335932.USD","LU0889566641.SGD","BSX","LU0310799852.SGD","LU0882574055.USD","LU2324357040.USD","SG9999001440.SGD","LU0122379950.USD","BK4082","LU0310800965.SGD","LU1291159041.SGD","BK4588","LU1804176565.USD","LU0052756011.USD","LU1989772840.SGD","LU0238689110.USD","LU0266013472.USD","LU2362541273.HKD","LU0792757196.USD","LU0048584097.USD"],"gpt_icon":1},{"id":"2514132882","title":"A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132882","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132882?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 17:03","pubTimestamp":1740733410,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical  and the best and worst performers in the medical devices & supplies - specialty industry.The 7 medical devices & supplies - specialty stocks we track reported a satisfactory Q3. As a group, revenues beat analysts’ consensus estimates by 0.9%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 11.5% since the latest earnings results.Founded in 1982, STAAR Surgical  develops and manufactures implantable lenses for vision correction, focusing on products designed to treat myopia, hyperopia, astigmatism, and presbyopia.“In the third quarter, we achieved double-digit sales growth against a macroeconomic environment that softened in the second half of the quarter, particularly in China,” said Tom Frinzi, President and CEO of STAAR Surgical.Is now the time to buy STAAR Surgic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/look-back-medical-devices-supplies-090330025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HAE","NDAQ","ITGR","INSP","STAA",".IXIC"],"gpt_icon":0},{"id":"2514491670","title":"3 Big Reasons to Love Inspire Medical Systems (INSP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514491670","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514491670?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 03:53","pubTimestamp":1740513184,"startTime":"0","endTime":"0","summary":"Since August 2024, Inspire Medical Systems has been in a holding pattern, posting a small loss of 2.8% while floating around $183.55. The stock also fell short of the S&P 500’s 6.1% gain during that period.Does this present a buying opportunity for INSP?Or is its underperformance reflective of its story and business quality?Find out in our full research report, it’s free.Founded in 2007, Inspire Medical Systems  develops and markets products for obstructive sleep apnea , with its flagship product being a neurostimulation system designed to improve breathing during sleep.Inspire Medical Systems’s number of domestic medical centers punched in at 1,435 in the latest quarter, and over the last two years, averaged 28.4% year-on-year growth. This pace was fast and gives the company more opportunities to increase its revenue.Stocks We Like Even More Than Inspire Medical Systems. Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-big-reasons-love-inspire-195304929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","BK4082","INSP","LU2065731478.USD"],"gpt_icon":0},{"id":"2514141750","title":"Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2514141750","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514141750?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 22:50","pubTimestamp":1740495007,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Is This 1 Momentum Stock a Screaming Buy Right Now?For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.Inspire Medical Systems, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-inspire-medical-systems-145007730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065731478.USD","BK4082","BK4167","INSP"],"gpt_icon":0},{"id":"2512094550","title":"3 US Stocks Estimated To Be 14.6% To 47.8% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2512094550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512094550?lang=en_us&edition=full_marsco","pubTime":"2025-02-17 18:02","pubTimestamp":1739786543,"startTime":"0","endTime":"0","summary":"As the U.S. stock market edges close to record highs, buoyed by positive wholesale inflation data and a stable tariff environment, investors are increasingly on the lookout for opportunities that may be trading below their intrinsic value. In this context, identifying undervalued stocks becomes crucial as these investments can offer potential upside in a market where major indices have recently posted weekly gains.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Duolingo is trading at US$432.69, approximately 14.6% below its estimated fair value of US$506.64, indicating potential undervaluation based on cash flows. The company's earnings are expected to grow significantly at 35.5% annually over the next three years, outpacing the broader U.S. market's growth rate of 14.5%. Recent product enhancements and a strategic board appointment bolster Duolingo's innovative edge and leadership capabilities in the education technology sector.Incyte is trading at US$70.42, signif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-stocks-estimated-14-100223953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DUOL","BK4539","IE00B7SZL793.SGD","INSP","BK4588","BK4134","BK4211","KD","IE00B19Z4B17.USD","BK4167","IE0031619046.USD","BK4204","BK4585","LU2065731478.USD","BK4153","CSTM","PFS","BK4195","INCY","BK4082","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2511540723","title":"Inspire Medical Systems: Strong Operational Performance and Future Growth Prospects Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2511540723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511540723?lang=en_us&edition=full_marsco","pubTime":"2025-02-13 21:46","pubTimestamp":1739454417,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on INSP stock, giving a Buy rating on February 11. Anthony Petrone ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/inspire-medical-systems-strong-operational-performance-and-future-growth-prospects-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/inspire-medical-systems-strong-operational-performance-and-future-growth-prospects-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","INSP","BK4082","LU2065731478.USD"],"gpt_icon":0},{"id":"2511548558","title":"Inspire Medical Systems, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions","url":"https://stock-news.laohu8.com/highlight/detail?id=2511548558","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511548558?lang=en_us&edition=full_marsco","pubTime":"2025-02-13 18:53","pubTimestamp":1739443998,"startTime":"0","endTime":"0","summary":"Shareholders might have noticed that Inspire Medical Systems, Inc.  filed its yearly result this time last week. The early response was not positive, with shares down 2.6% to US$187 in the past week. Revenues were US$803m, approximately in line with whatthe analysts expected, although statutory earnings per share  crushed expectations, coming in at US$1.75, an impressive 32% ahead of estimates. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest  post-earnings forecasts for next year.See our latest analysis for Inspire Medical Systems","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspire-medical-systems-inc-just-105318052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"gpt_icon":0},{"id":"2510345711","title":"U.S. RESEARCH ROUNDUP-Edison International, Onestream, Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2510345711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510345711?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 15:21","pubTimestamp":1739344879,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Edison International, Onestream, Vertex PharmaceuticalsFeb 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nL4N3P30JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","AFL","LU1066051498.USD","FRSH","BK4504","LYFT","FIS","GILD","MOH","EIX","DASH","PFG","COTY","MET","PCG","POST","INSP","CNO","CG","MAR","KDP","CFLT","ECL","LDOS","MNST","PRU","CNA","TVTX","UNM","ARI","OS","PPG","L","HUM","BYD","LH","LU2279689827.SGD","LNC","GL","EDR","FLNC","WCC","ST","ALSN","EQH","ADPT"],"gpt_icon":1},{"id":"2510315995","title":"Inspire Medical Systems Inc : JP Morgan Cuts Target Price to $235 From $265","url":"https://stock-news.laohu8.com/highlight/detail?id=2510315995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510315995?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 12:39","pubTimestamp":1739335189,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P308N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INSP","BK4082","LU2065731478.USD","BK4167"],"gpt_icon":0},{"id":"2510633012","title":"Inspire Medical Systems Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2510633012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510633012?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 01:52","pubTimestamp":1739296320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INSP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 12:52 ET (17:52 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"gpt_icon":0},{"id":"2510308843","title":"Inspire Medical Systems Price Target Maintained With a $260.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2510308843","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510308843?lang=en_us&edition=full_marsco","pubTime":"2025-02-12 01:22","pubTimestamp":1739294520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INSP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 12:22 ET (17:22 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inspiresleep.com","stockEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.1248},{"period":"3month","weight":-0.137},{"period":"6month","weight":-0.194},{"period":"1year","weight":-0.2164},{"period":"ytd","weight":-0.1197}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0479},{"period":"3month","weight":-0.0545},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.096},{"period":"ytd","weight":-0.0298}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.056512},{"month":2,"riseRate":0.714286,"avgChangeRate":0.056787},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.06597},{"month":4,"riseRate":0.666667,"avgChangeRate":0.05222},{"month":5,"riseRate":0.5,"avgChangeRate":-0.056639},{"month":6,"riseRate":0.714286,"avgChangeRate":0.044328},{"month":7,"riseRate":0.714286,"avgChangeRate":0.077932},{"month":8,"riseRate":0.714286,"avgChangeRate":0.093921},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.037182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.028614},{"month":11,"riseRate":0.571429,"avgChangeRate":0.12974},{"month":12,"riseRate":0.714286,"avgChangeRate":0.058987}],"exchange":"NYSE","name":"Inspire Medical Systems","nameEN":"Inspire Medical Systems"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inspire Medical Systems(INSP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inspire Medical Systems(INSP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inspire Medical Systems,INSP,Inspire Medical Systems股票,Inspire Medical Systems股票老虎,Inspire Medical Systems股票老虎国际,Inspire Medical Systems行情,Inspire Medical Systems股票行情,Inspire Medical Systems股价,Inspire Medical Systems股市,Inspire Medical Systems股票价格,Inspire Medical Systems股票交易,Inspire Medical Systems股票购买,Inspire Medical Systems股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inspire Medical Systems(INSP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inspire Medical Systems(INSP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction